Unknown

Dataset Information

0

Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2.


ABSTRACT: Individuals with the rare developmental disorder fibrodysplasia ossificans progressiva (FOP) experience disabling heterotopic ossification caused by a gain of function mutation in the intracellular region of the BMP type I receptor kinase ALK2, encoded by the gene ACVR1. Small molecule BMP type I receptor inhibitors that block this ossification in FOP mouse models have been derived from the pyrazolo[1,5-a]pyrimidine scaffold of dorsomorphin. While the first derivative LDN-193189 exhibited pan inhibition of BMP receptors, the more recent compound LDN-212854 has shown increased selectivity for ALK2. Here we solved the crystal structure of ALK2 in complex with LDN-212854 to define how its binding interactions compare to previously reported BMP and TGF? receptor inhibitors. LDN-212854 bound to the kinase hinge region as a typical type I ATP-competitive inhibitor with a single hydrogen bond to ALK2 His286. Specificity arising from the 5-quinoline moiety was associated with a distinct pattern of water-mediated hydrogen bonds involving Lys235 and Glu248 in the inactive conformation favoured by ALK2. The structure of this complex provides a template for the design of future ALK2 inhibitors under development for the treatment of FOP and other related conditions of heterotopic ossification.

SUBMITTER: Williams E 

PROVIDER: S-EPMC5871398 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2.

Williams Eleanor E   Bullock Alex N AN  

Bone 20170912


Individuals with the rare developmental disorder fibrodysplasia ossificans progressiva (FOP) experience disabling heterotopic ossification caused by a gain of function mutation in the intracellular region of the BMP type I receptor kinase ALK2, encoded by the gene ACVR1. Small molecule BMP type I receptor inhibitors that block this ossification in FOP mouse models have been derived from the pyrazolo[1,5-a]pyrimidine scaffold of dorsomorphin. While the first derivative LDN-193189 exhibited pan in  ...[more]

Similar Datasets

| S-EPMC8368100 | biostudies-literature
| S-EPMC3901569 | biostudies-literature
2021-08-16 | PXD022944 | Pride
| S-EPMC387321 | biostudies-literature
| S-EPMC5755682 | biostudies-literature
| S-EPMC7911104 | biostudies-literature
| S-EPMC4376569 | biostudies-literature
| S-EPMC4945863 | biostudies-literature
| S-EPMC6926456 | biostudies-literature
| S-EPMC3800496 | biostudies-literature